Cornerstone Capital Management Holdings’s AMAG Pharmaceuticals AMAG Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,351	Closed	-$227K	–	1357
2017 Q3	$227K	Sell	12,351 -12,350	-50%	-$230K	﹤0.01%	1148
2017 Q2	$454K	Buy	24,701 +1,835	+8%	+$36.4K	﹤0.01%	1052
2017 Q1	$515K	Buy	22,866 +18,966	+486%	+$454K	﹤0.01%	1055
2016 Q4	$135K	Sell	3,900 -34,900	-90%	-$1.04M	﹤0.01%	1226
2016 Q3	$950K	Buy	38,800 +13,800	+55%	+$345K	0.01%	951
2016 Q2	$598K	Buy	25,000 +19,400	+346%	+$445K	﹤0.01%	996
2016 Q1	$131K	Sell	5,600 -44,008	-89%	-$1.04M	﹤0.01%	1280
2015 Q4	$1.5M	Buy	49,608 +42,208	+570%	+$1.36M	0.01%	805
2015 Q3	$294K	Buy	7,400 +4,900	+196%	+$304K	﹤0.01%	1142
2015 Q2	$173K	Buy	2,500 +1,700	+213%	+$107K	﹤0.01%	1218
2015 Q1	$44K	Sell	800 -8,900	-92%	-$424K	﹤0.01%	1319
2014 Q4	$414K	Sell	9,700 -55,899	-85%	-$2.02M	﹤0.01%	997
2014 Q3	$2.09M	Sell	65,599 -85,301	-57%	-$1.82M	0.02%	667
2014 Q2	$3.13M	Buy	150,900 +70,000	+87%	+$1.29M	0.03%	551
2014 Q1	$1.56M	Buy	80,900 +38,839	+92%	+$825K	0.02%	769
2013 Q4	$1.02M	Buy	42,061 +19,500	+86%	+$459K	0.01%	826
2013 Q3	$484K	Sell	22,561 -13,300	-37%	-$314K	0.01%	937
2013 Q2	$798K	Buy	+35,861	New	+$790K	0.01%	847

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cornerstone Capital Management Holdings's AMAG Position: Q4 2017 in Review

Cornerstone Capital Management Holdings sold out of AMAG Pharmaceuticals (AMAG) in Q4 2017, closing a stake of 12,351 shares — an estimated $227K sold.

Cornerstone Capital Management Holdings first reported a position in AMAG in Q2 2013 and held it in 18 quarters. The position peaked at $3.13M in Q2 2014. 170 funds tracked by Wall St. Rank hold AMAG as of Q4 2017.

Cornerstone Capital Management Holdings reported no remaining AMAG Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 12,351 AMAG Pharmaceuticals shares in Q4 2017, an estimated $227K.
Cornerstone Capital Management Holdings first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 18 quarters.
Cornerstone Capital Management Holdings's AMAG Pharmaceuticals position peaked at $3.13M in Q2 2014.
170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.